Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
 [1]
Current Assets:    
Cash and cash equivalents $ 36,184 $ 50,612
Restricted cash 23,799 11,513
Accounts receivable (net of allowance for doubtful accounts of $409 and $378, respectively) 80,611 86,888
Inventories 58,491 54,373
Derivative instruments 19,498 15,839
Notes receivable, current 12,385 3,125
Other current assets 10,245 7,176
Total current assets 241,213 229,526
Property and equipment, net 220,996 222,550
Other Assets:    
Right of use operating lease assets, net 15,099 13,413
Notes receivable, noncurrent 11,641
Intangible assets, net 9,460 2,678
Goodwill 5,958
Other assets 5,142 5,145
Total other assets 35,659 32,877
Total Assets 497,868 484,953
Current Liabilities:    
Accounts payable – trade 21,750 23,251
Accrued liabilities 19,479 21,307
Current portion – operating leases 4,297 3,909
Derivative instruments 27,487 13,582
Other current liabilities 7,168 7,553
Total current liabilities 80,181 69,602
Long-term debt 53,681 50,361
Operating leases, net of current portion 10,705 9,382
Other liabilities 10,336 10,394
Total Liabilities 154,903 139,739
Commitments and Contingencies (Note 7)
Alto Ingredients, Inc. Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of March 31, 2022 and December 31, 2021; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of March 31, 2022 and December 31, 2021; liquidation preference of $18,075 as of March 31, 2022 1 1
Common stock, $0.001 par value; 300,000 shares authorized; 74,411 and 72,778 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 74 73
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of March 31, 2022 and December 31, 2021
Additional paid-in capital 1,037,869 1,037,205
Accumulated other comprehensive loss (284) (284)
Accumulated deficit (694,695) (691,781)
Total Stockholders’ Equity 342,965 345,214
Total Liabilities and Stockholders’ Equity $ 497,868 $ 484,953
[1] Amounts derived from the audited financial statements for the year ended December 31, 2021.